Cargando…
Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
[Image: see text] A robust preclinical disease model is a primary requirement to understand the underlying mechanisms, signaling pathways, and drug screening for human diseases. Although various preclinical models are available for several diseases, clinical models for Alzheimer’s disease (AD) remai...
Autores principales: | Akhtar, Ansab, Gupta, Shraddha M., Dwivedi, Shubham, Kumar, Devendra, Shaikh, Mohd. Farooq, Negi, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798399/ https://www.ncbi.nlm.nih.gov/pubmed/36591205 http://dx.doi.org/10.1021/acsomega.2c05609 |
Ejemplares similares
-
Monkeypox infection: The past, present, and future
por: Upadhayay, Shubham, et al.
Publicado: (2022) -
Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014) -
Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020) -
Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer’s: Design, Synthesis, and Biological Evaluation
por: Gupta, Shraddha Manish, et al.
Publicado: (2022) -
The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
por: Xu, Joshua, et al.
Publicado: (2016)